Skip to content
Screener

Neogen NEOG Pre-Tax Income

Pre-Tax Income at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$1.92B
Idexx Laboratories logo
Idexx LaboratoriesIDXX
$417.22M+15.1%
Zoetis logo
ZoetisZTS
$866M-5.0%
Revvity logo
RevvityRVTY
$49.99M-4.6%
Merck & Co. logo
Merck & Co.MRK
-$683M-114%
TEC
Bio-TechneTECH
$71.23M+86.1%

Other financials

Income statement

See full
Revenue$211.2M-4.4%
Gross profit$99.0M-10.2%
Operating income-$3.3M-161%
Net income-$17.0M-56.0%
EPS (diluted)-$0.08-60.0%

Balance sheet

See full
Cash & equivalents$159.9M+25.2%
Total debt$793.3M-11.2%
Total equity$2.1B-21.0%
Total assets$3.4B-16.8%

Cash flow

See full
Operating cash flow$22.7M+16.7%
CapEx$11.6M-64.7%
Free cash flow$11.1M+182%

Valuation

See full
Market cap$2.5B+125%
Enterprise value$3.13B+65.3%
P/S2.9×+1.6×

Profitability

See full
Gross margin45.2%-3.6pp
Operating margin-73.1%+77.7pp
Net margin-69.9%+30.8pp
FCF margin-14%

Returns & leverage

See full
Return on equity-25.6%+28.8pp
Debt / equity0.4×0.0×
Current ratio3.9×0.0×

Where this comes from

Reported directly by Neogen in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.

The source filing: Neogen’s 10-Q, filed April 9, 2026.

Filed
Apr 9, 2026, 4:03 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-149599
Line itemThree months ended February 28, 2026Three months ended February 28, 2025Nine months ended February 28, 2026Nine months ended February 28, 2025
Gain on sale of business76.4
Other, net(3.1)1.9(4.9)(0.1)
Total Other (Expense) Income(17.0)(15.1)27.8(52.1)
(Loss) Income Before Taxes(20.3)(9.7)3.1(501.9)
Income Tax (Benefit) Expense(3.3)1.2(0.3)(22.1)
Net (Loss) Income$(17.0)$(10.9)$3.4$(479.8)
Net (Loss) Income Per Share
Basic$(0.08)$(0.05)$0.02$(2.21)

Item 1. Interim Condensed Consolidated Financial Statements

FAQ

What is Neogen's pre-tax income?
Neogen (NEOG) reported pre-tax income of -$20.3M in Q4 2025.
How has Neogen's pre-tax income changed year-over-year?
Neogen's pre-tax income decreased by 109.3% year-over-year, from -$9.7M to -$20.3M.
What is the long-term trend for Neogen's pre-tax income?
Over 2 years (2022 to 2025), Neogen's pre-tax income has grown at a 333.8% compound annual growth rate (CAGR), from $60.21M to -$1.13B.
What does pre-tax income mean?
Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.

Ask your AI about Neogen's pre-tax income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude